<VariationArchive VariationID="2889" VariationName="NM_000419.5(ITGA2B):c.409-2_419del" VariationType="Deletion" Accession="VCV000002889" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-23" DateCreated="2021-04-18" MostRecentSubmission="2021-08-27">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="17928" VariationID="2889">
      <GeneList>
        <Gene Symbol="ITGA2B" FullName="integrin subunit alpha 2b" GeneID="3674" HGNC_ID="HGNC:6138" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="44372181" stop="44389649" display_start="44372181" display_stop="44389649" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="42449549" stop="42466872" display_start="42449549" display_stop="42466872" Strand="-" />
          </Location>
          <OMIM>607759</OMIM>
        </Gene>
        <Gene Symbol="LOC130060983" FullName="ATAC-STARR-seq lymphoblastoid active region 12261" GeneID="130060983" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>17q21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="44385710" stop="44385849" display_start="44385710" display_stop="44385849" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000419.5(ITGA2B):c.409-2_419del</Name>
      <CanonicalSPDI>NC_000017.11:44385705:GGGGCGCAGGCCTGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q21.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="44385706" stop="44385718" display_start="44385706" display_stop="44385718" variantLength="13" positionVCF="44385705" referenceAlleleVCF="GGGGGCGCAGGCCT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="42463074" stop="42463086" display_start="42463074" display_stop="42463086" variantLength="13" positionVCF="42463073" referenceAlleleVCF="GGGGGCGCAGGCCT" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008331.1" sequenceAccession="NG_008331" sequenceVersion="1" change="g.8788_8800del">
            <Expression>NG_008331.1:g.8788_8800del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_479" sequenceAccession="LRG_479" change="g.8788_8800del">
            <Expression>LRG_479:g.8788_8800del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.42463076_42463088del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.42463076_42463088del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.44385708_44385720del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.44385708_44385720del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000419.5" sequenceAccession="NM_000419" sequenceVersion="5" change="c.409-2_419del" MANESelect="true">
            <Expression>NM_000419.5:c.409-2_419del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000419.5" sequenceAccession="NM_000419" sequenceVersion="5" change="c.409-2_419del" MANESelect="true">
            <Expression>NM_000419.5(ITGA2B):c.409-2_419del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10575471" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="607759.0002" DB="OMIM" />
        <XRef Type="rs" ID="879255508" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000419.5(ITGA2B):c.409-2_419del AND Glanzmann thrombasthenia 1" Accession="RCV000003023" Version="4">
        <ClassifiedConditionList TraitSetID="69322">
          <ClassifiedCondition DB="MedGen" ID="CN300358">Glanzmann thrombasthenia 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1991-07-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000419.5(ITGA2B):c.409-2_419del AND Glanzmann thrombasthenia" Accession="RCV001580260" Version="2">
        <ClassifiedConditionList TraitSetID="734">
          <ClassifiedCondition DB="MedGen" ID="C0040015">Glanzmann thrombasthenia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2021-05-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-05-07" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2021-04-18" MostRecentSubmission="2021-08-27">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16359514</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1926040</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/4d6a641c-0498-4bd3-8eb1-854be8a92082</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="69322" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="57264" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Glanzmann thrombasthenia 1</ElementValue>
                <XRef ID="MONDO:0031332" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GP IIb-IIIa COMPLEX DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="273800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GLYCOPROTEIN COMPLEX IIb-IIIa DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="273800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PLATELET FIBRINOGEN RECEPTOR DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="273800" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">GT</ElementValue>
                <XRef Type="MIM" ID="273800" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">GT1</ElementValue>
                <XRef Type="MIM" ID="273800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15240" />
                <XRef ID="15240" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="CN300358" DB="MedGen" />
              <XRef ID="MONDO:0031332" DB="MONDO" />
              <XRef Type="MIM" ID="273800" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="734" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3893" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PLATELET GLYCOPROTEIN IIb-IIIa DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="273800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thrombasthenia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BLEEDING DISORDER, PLATELET-TYPE, 2</ElementValue>
                <XRef Type="MIM" ID="273800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glanzmann's thrombasthenia</ElementValue>
                <XRef ID="Thrombasthenia+of+Glanzmann+and+Naegeli/7074" DB="Genetic Alliance" />
                <XRef ID="32942005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thrombasthenia of Glanzmann and Naegeli</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glanzmann thrombasthenia</ElementValue>
                <XRef ID="MONDO:0100326" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glanzmann thrombasthenia type A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Diacyclothrombopathia 2B 3A</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BDPLT2</ElementValue>
                <XRef Type="MIM" ID="273800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2478" />
                <XRef ID="2478" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="849" DB="Orphanet" />
              <XRef ID="C0040015" DB="MedGen" />
              <XRef ID="MONDO:0100326" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS273800" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="23181" SubmissionDate="2021-04-13" DateLastUpdated="2021-04-18" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607759.0002_GLANZMANN THROMBASTHENIA 1" title="ITGA2B, 13-BP DEL_GLANZMANN THROMBASTHENIA 1" />
        <ClinVarAccession Accession="SCV000023181" DateUpdated="2021-04-18" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1991-07-12">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 Arab kindreds with Glanzmann thrombasthenia (GT1; 273800), Newman et al. (1991) identified a 13-bp deletion encompassing the splice acceptor site of exon 4 of the GPIIb gene. The deletion results in forced alternative splicing to a downstream AG acceptor, producing a 6-amino acid deletion (residues 106 to 111), including one cysteine residue. As a result, the GPIIb molecule is probably improperly folded.</Attribute>
              <Citation>
                <ID Source="PubMed">1926040</ID>
              </Citation>
              <XRef DB="OMIM" ID="273800" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITGA2B" />
          </GeneList>
          <Name>ITGA2B, 13-BP DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">13-BP DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607759.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GLANZMANN THROMBASTHENIA 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="3550724" SubmissionDate="2021-08-25" DateLastUpdated="2021-08-27" DateCreated="2021-08-27">
        <ClinVarSubmissionID localKey="4d6a641c-0498-4bd3-8eb1-854be8a92082" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001809922" DateUpdated="2021-08-27" DateCreated="2021-08-27" Type="SCV" Version="1" SubmitterName="ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen" OrgID="507662" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-05-07">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16359514</ID>
          </Citation>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/4d6a641c-0498-4bd3-8eb1-854be8a92082</URL>
          </Citation>
          <Comment>The c.409-2_419del variant was first reported in the Palestinian population by PMID: 2014236; haplotype analysis in PMID: 16359514 is consistent with a founder effect. This variant has also been described as c.409-3_418del and HGVS nomenclature is c.409-4_417del. The deletion causes use of a cryptic splice site at position c.425_426 (confirmed in patient mRNA in PMID: 2014236). As such there is an in-frame deletion of 18bp encompassing 6 amino acids (Ala137 through Gln142) in the critical ligand binding beta-propeller domain. This variant is absent from all population databases, including gnomAD. The variant has been identified homozygous in at least 8 patients (PMIDs: 2014236, 16359514). with a phenotype highly specific to GT. Transfection in BHK cells resulted in lack of surface expression of Î±IIbÎ²3 (PMID: 16359514). In summary this variant is classified as Pathogenic for GT. GT-specific criteria applied: PVS1_strong, PS3, PM2_supporting, PM3, PP4_strong.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen Platelet ACMG Specifications v2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/r2stlucp/clingen_platelet_acmg_specifications_v2.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITGA2B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000419.5(ITGA2B):c.409-2_419del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.11:g.44385708_44385720del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0100326" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10236687</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3550724" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0100326" MappingRef="MONDO">
        <MedGen CUI="C0040015" Name="Glanzmann thrombasthenia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="23181" TraitType="Disease" MappingType="Name" MappingValue="GLANZMANN THROMBASTHENIA 1" MappingRef="Preferred">
        <MedGen CUI="CN300358" Name="Glanzmann thrombasthenia 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

